Literature DB >> 7540068

The functional characterization of interleukin-10 receptor expression on human natural killer cells.

W E Carson1, M J Lindemann, R Baiocchi, M Linett, J C Tan, C C Chou, S Narula, M A Caligiuri.   

Abstract

Human natural killer (NK) cells are large granular lymphocytes that constitutively express functional forms of the interleukin-2 receptor (IL-2R) and lyse tumor and virally infected cells without prior sensitization. NK cells with high density expression of CD56 (CD56bright) express the high affinity IL-2R and proliferate in response to low (picomolar) concentrations of IL-2. CD56dim NK cells express the intermediate affinity IL-2R and demonstrate enhanced cytotoxic activity without proliferation in response to high (nanomolar) concentrations of IL-2. In the present study, we characterized IL-10R expression on human NK cells and the functional consequences of IL-10 binding directly to highly purified subsets of CD56bright and CD56dim NK cells. Binding studies using 125I-IL-10 indicated that resting human NK cells constitutively express the IL-10 receptor protein at a surface density of approximately 90 receptor sites per cell, with a kd of approximately 1 nmol/L. Alone, IL-10 did not induce proliferation of CD56bright or CD56dim NK cell subsets. However, at low concentrations (0.5 to 5 ng/mL), IL-10 significantly augmented IL-2-induced proliferation of the CD56bright NK cell subset mediated via the high-affinity IL-2R. In the absence of IL-2, IL-10 was able to induce significant NK cytotoxic activity against NK-resistant tumor cell targets in both subsets of NK cells in a dose-dependent fashion. Furthermore, the combination of IL-10 and IL-2 had an additive effect on NK cytotoxic activity, whereas that of IL-10 and IL-12 did not. Production of interferon-gamma, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor by IL-2-activated NK cells was also significantly enhanced by IL-10. Neither resting nor activated human NK cells appear to produce human IL-10 protein. In summary, NK cells constitutively express the IL-10R protein in low density, and the functional consequences of IL-10 binding directly to human NK cell subsets appear to be stimulatory and dose-dependent. In contrast to its direct effects on human T cells and monocytes/macrophages, IL-10 potentiates cytokine production by human NK cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540068

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.

Authors:  Elizabeth L McMichael; Alena Cristina Jaime-Ramirez; Kristan D Guenterberg; Eric Luedke; Lakhvir S Atwal; Amanda R Campbell; Zhiwei Hu; Armika S Tatum; Sri Vidya Kondadasula; Xiaokui Mo; Susheela Tridandapani; Mark Bloomston; E Christopher Ellison; Terence M Williams; Tanios Bekaii-Saab; William E Carson
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

3.  Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.

Authors:  Elizabeth L McMichael; Nicholas B Courtney; Megan C Duggan; Robert Wesolowski; Dionisia Quiroga; Sri Vidya Kondadasula; Lakhvir S Atwal; Neela Bhave; Eric Luedke; Alena Cristina Jaime-Ramirez; Amanda R Campbell; Xiaokui Mo; John C Byrd; William E Carson Iii
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

4.  Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization.

Authors:  Shuang-Jian Qiu; Lina Lu; Chunping Qiao; LiangFu Wang; Zhong Wang; Xiao Xiao; Shiguang Qian; John J Fung; Sheng-Long Ye; C Andrew Bonham
Journal:  J Cancer Res Clin Oncol       Date:  2005-04-08       Impact factor: 4.553

5.  Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

Authors:  A D Santin; P L Hermonat; A Ravaggi; S Bellone; S Pecorelli; J J Roman; G P Parham; M J Cannon
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Differential cytokine expression in EBV positive peripheral T cell lymphomas.

Authors:  J W Ho; R H Liang; G Srivastava
Journal:  Mol Pathol       Date:  1999-10

7.  Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.

Authors:  Xing-Xing Yu; Ting-Ting Han; Ling-Ling Xu; Ying-Jun Chang; Xiao-Jun Huang; Xiang-Yu Zhao
Journal:  J Cell Mol Med       Date:  2018-03-25       Impact factor: 5.310

Review 8.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Oral glucocorticoid treatment decreases interleukin-10 receptor expression on peripheral blood leucocyte subsets.

Authors:  M Moniuszko; A Bodzenta-Lukaszyk; M Dabrowska
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

Review 10.  Role of Nod2 in the development of Crohn's disease.

Authors:  Soichiro Yamamoto; Xiaojing Ma
Journal:  Microbes Infect       Date:  2009-06-30       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.